Researchers found and developed nanoparticles that simultaneously carry chemotherapy and a new immunotherapy. Chemotherapy is a pillar of cancer treatment, but residual cancer cells can persist and cause tumor relapse.
Researchers from the University of Pittsburgh have designed cancer-fighting nanoparticles that co-deliver a chemotherapy drug and a novel immunotherapy.
The molecular and microbiological composition of human skin may change as a result of skin conditions, according to researchers. Making it a valuable source of data regarding our physical health.
Irvine (California) [US]/ Bangalore (Karnataka) [India], November 9 (ANI/BusinessWire India): Eoxys Systems, an IoT solutions provider, today announced the availability of its XENO+™ WiFi+BLE Nano ML Module, an Alexa-enabled machine learning circuit board with embedded Syntiant technol
Plant-derived materials such as cellulose often exhibit thermally insulating properties. A new material made from nanoscale cellulose fibers shows the reverse, high thermal conductivity.
Plant-derived materials such as cellulose often exhibit thermally insulating properties. A new material made from nanoscale cellulose fibres shows the reverse, high thermal conductivity. This makes it useful in areas previously dominated by synthetic polymer materials. Materials based on cel
Researchers found that focusing on cellulose-based materials could result in more environmentally friendly technology applications when thermal conductivity is required because they are more environmentally friendly than polymers.
New Delhi [India], November 4 (ANI/SRV): Nitte (Deemed to be University) is holding its 12th Annual Convocation on November 5, 2022, at 10.00 AM in the presence of the Chancellor, Sri. N. Vinaya Hegde at Nitte Grounds, KSHEMA campus. The Chief Guest, Prof Mamidala Jagadesh Kumar, Chairperson
A team of Canadian researchers from Universite de Montreal has designed and validated a new class of drug transporters made of DNA that are 20,000 times smaller than a human hair and that could improve how cancers and other diseases are treated
Missouri [US], October 20 (ANI): After 14 months, there is a 70-80 per cent risk that non-small cell lung cancer, one of the two primary types of lung cancer, would become resistant to the pharmacological therapy that was initially used to treat it. There aren't many existing therapy alterna